JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, J.
Right arrow Articles by Chen, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, J.
Right arrow Articles by Chen, X.

J Biol Chem, Vol. 273, Issue 21, 13030-13036, May 22, 1998

Identification of a Novel p53 Functional Domain That Is Necessary for Mediating Apoptosis

Jianhui Zhu, Wenjing Zhou, Jieyuan Jiang, and Xinbin Chen

From the Program in Gene Regulation, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia 30912

The ability of p53 to induce apoptosis requires its sequence-specific DNA binding activity; however, the transactivation-deficient p53(Gln22-Ser23) can still induce apoptosis. Previously, we have shown that the region between residues 23 and 97 in p53 is necessary for such activity. In an effort to more precisely map a domain necessary for apoptosis within the N terminus, we found that deletion of the N-terminal 23 amino acids compromises, but does not abolish, p53 induction of apoptosis. Surprisingly, p53(Delta 1-42), which lacks the N-terminal 42 amino acids and the previously defined activation domain, retains the ability to induce apoptosis to an even higher level than wild-type p53. A more extensive deletion, which eliminates the N-terminal 63 amino acids, renders p53 completely inert in mediating apoptosis. In addition, we found that both p53(Delta 1-42) and p53(Gln22-Ser23) can activate a subset of cellular p53 targets. Furthermore, we showed that residues 53 and 54 are critical for the apoptotic and transcriptional activities of both p53(Delta 1-42) and p53(Gln22-Ser23). Taken together, these data suggest that within residues 43-63 lie an apoptotic domain as well as another transcriptional activation domain. We therefore postulate that the apoptotic activity in p53(Gln22-Ser23) and p53(Delta 1-42) is still transcription-dependent.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. M. Gamper and R. G. Roeder
Multivalent Binding of p53 to the STAGA Complex Mediates Coactivator Recruitment after UV Damage
Mol. Cell. Biol., April 15, 2008; 28(8): 2517 - 2527.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Baptiste-Okoh, A. M. Barsotti, and C. Prives
A role for caspase 2 and PIDD in the process of p53-mediated apoptosis
PNAS, February 12, 2008; 105(6): 1937 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. M. Johnson, K. Meade, N. Pathak, M. R. Marques, and L. D. Attardi
Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence
PNAS, January 29, 2008; 105(4): 1215 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Di Lello, L. M. Miller Jenkins, C. Mas, C. Langlois, E. Malitskaya, A. Fradet-Turcotte, J. Archambault, P. Legault, and J. G. Omichinski
p53 and TFIIE{alpha} share a common binding site on the Tfb1/p62 subunit of TFIIH
PNAS, January 8, 2008; 105(1): 106 - 111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu, J. Zhang, and X. Chen
The Activity of p53 Is Differentially Regulated by Brm- and Brg1-containing SWI/SNF Chromatin Remodeling Complexes
J. Biol. Chem., December 28, 2007; 282(52): 37429 - 37435.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Yan and X. Chen
Targeted Repression of Bone Morphogenetic Protein 7, a Novel Target of the p53 Family, Triggers Proliferative Defect in p53-Deficient Breast Cancer Cells
Cancer Res., October 1, 2007; 67(19): 9117 - 9124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Scoumanne and X. Chen
The Lysine-specific Demethylase 1 Is Required for Cell Proliferation in Both p53-dependent and -independent Manners
J. Biol. Chem., May 25, 2007; 282(21): 15471 - 15475.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. P. Teufel, S. M. Freund, M. Bycroft, and A. R. Fersht
Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53
PNAS, April 24, 2007; 104(17): 7009 - 7014.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. L. Harms and X. Chen
Histone Deacetylase 2 Modulates p53 Transcriptional Activities through Regulation of p53-DNA Binding Activity
Cancer Res., April 1, 2007; 67(7): 3145 - 3152.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu and X. Chen
Glyoxalase II, a Detoxifying Enzyme of Glycolysis Byproduct Methylglyoxal and a Target of p63 and p73, Is a Pro-survival Factor of the p53 Family
J. Biol. Chem., September 8, 2006; 281(36): 26702 - 26713.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Scoumanne and X. Chen
The Epithelial Cell Transforming Sequence 2, a Guanine Nucleotide Exchange Factor for Rho GTPases, Is Repressed by p53 via Protein Methyltransferases and Is Required for G1-S Transition.
Cancer Res., June 15, 2006; 66(12): 6271 - 6279.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. M. Hammond, D. J. Mandell, A. Salim, A. J. Krieg, T. M. Johnson, H. A. Shirazi, L. D. Attardi, and A. J. Giaccia
Genome-Wide Analysis of p53 under Hypoxic Conditions.
Mol. Cell. Biol., May 1, 2006; 26(9): 3492 - 3504.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Enari, K. Ohmori, I. Kitabayashi, and Y. Taya
Requirement of clathrin heavy chain for p53-mediated transcription
Genes & Dev., May 1, 2006; 20(9): 1087 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Yan and X. Chen
GPX2, a Direct Target of p63, Inhibits Oxidative Stress-induced Apoptosis in a p53-dependent Manner
J. Biol. Chem., March 24, 2006; 281(12): 7856 - 7862.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Liu and X. Chen
DNA Polymerase {eta}, the Product of the Xeroderma Pigmentosum Variant Gene and a Target of p53, Modulates the DNA Damage Checkpoint and p53 Activation
Mol. Cell. Biol., February 15, 2006; 26(4): 1398 - 1413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Helton, J. Zhu, and X. Chen
The Unique NH2-terminally Deleted ({Delta}N) Residues, the PXXP Motif, and the PPXY Motif Are Required for the Transcriptional Activity of the {Delta}N Variant of p63
J. Biol. Chem., February 3, 2006; 281(5): 2533 - 2542.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J.-C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D. P. Xirodimas, M. K. Saville, and D. P. Lane
p53 isoforms can regulate p53 transcriptional activity
Genes & Dev., September 15, 2005; 19(18): 2122 - 2137.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. L. Harms and X. Chen
The C Terminus of p53 Family Proteins Is a Cell Fate Determinant
Mol. Cell. Biol., March 1, 2005; 25(5): 2014 - 2030.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. M. Chan, W. Y. Siu, A. Lau, and R. Y. C. Poon
How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer?
Mol. Cell. Biol., April 15, 2004; 24(8): 3536 - 3551.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Liu, T. Xia, and X. Chen
The Activation Domains, the Proline-rich Domain, and the C-terminal Basic Domain in p53 Are Necessary for Acetylation of Histones on the Proximal p21 Promoter and Interaction with p300/CREB-binding Protein
J. Biol. Chem., May 2, 2003; 278(19): 17557 - 17565.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. M. Minter, E. S. Dickinson, S. P. Naber, and D. J. Jerry
Epithelial cell cycling predicts p53 responsiveness to {gamma}-irradiation during post-natal mammary gland development
Development, March 8, 2003; 129(12): 2997 - 3008.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Matsuda, K. Yoshida, Y. Taya, K. Nakamura, Y. Nakamura, and H. Arakawa
p53AIP1 Regulates the Mitochondrial Apoptotic Pathway
Cancer Res., May 1, 2002; 62(10): 2883 - 2889.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Herr and K.-M. Debatin
Cellular stress response and apoptosis in cancer therapy
Blood, November 1, 2001; 98(9): 2603 - 2614.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Koumenis, R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, Y. Taya, S. W. Lowe, M. Kastan, et al.
Regulation of p53 by Hypoxia: Dissociation of Transcriptional Repression and Apoptosis from p53-Dependent Transactivation
Mol. Cell. Biol., February 15, 2001; 21(4): 1297 - 1310.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. Majumder, A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray
Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent Manner
J. Virol., February 1, 2001; 75(3): 1401 - 1407.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
K. Chylicki, M. Ehinger, H. Svedberg, and U. Gullberg
Characterization of the Molecular Mechanisms for p53-mediated Differentiation
Cell Growth Differ., November 1, 2000; 11(11): 561 - 571.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
J. Zhu and X. Chen
MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M
Mol. Cell. Biol., August 1, 2000; 20(15): 5602 - 5618.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
B. Powell, R. Soong, B. Iacopetta, R. Seshadri, and D. R. Smith
Prognostic Significance of Mutations to Different Structural and Functional Regions of the p53 Gene in Breast Cancer
Clin. Cancer Res., February 1, 2000; 6(2): 443 - 451.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. F. Lambert, F. Kashanchi, M. F. Radonovich, R. Shiekhattar, and J. N. Brady
Phosphorylation of p53 Serine 15 Increases Interaction with CBP
J. Biol. Chem., December 4, 1998; 273(49): 33048 - 33053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Cain, S. Miller, J. Ahn, and C. Prives
The N Terminus of p53 Regulates Its Dissociation from DNA
J. Biol. Chem., December 15, 2000; 275(51): 39944 - 39953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhu, S. Zhang, J. Jiang, and X. Chen
Definition of the p53 Functional Domains Necessary for Inducing Apoptosis
J. Biol. Chem., December 15, 2000; 275(51): 39927 - 39934.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.